Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jue Zeng

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53Ting Wang, Jue Zeng, Craig B Lowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2004
A global suppressor motif for p53 cancer mutantsTimothy E Baroni, Ting Wang, Hua Qian, et al.
Nucleic Acids Research|December 19, 2007
Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteinsJue Zeng, Jizhou Yan, Ting Wang, et al.
Analytical Biochemistry|January 24, 2017
Split luciferase-based biosensors for characterizing EED bindersLing Li, Lijian Feng, Minlong Shi, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|October 20, 2006
Functional census of mutation sequence spaces: the example of p53 cancer rescue mutantsSamuel A Danziger, S Joshua Swamidass, Jue Zeng, et al.
Nature Communications|November 2, 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapiesElizabeth J Carstens, Kazuki Takahashi, Naoya Sakamoto, et al.
Journal of Medicinal Chemistry|December 20, 2016
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) MethyltransferaseAndreas Lingel, Martin Sendzik, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53Ting Wang, Jue Zeng, Craig B Lowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2004
A global suppressor motif for p53 cancer mutantsTimothy E Baroni, Ting Wang, Hua Qian, et al.
Nucleic Acids Research|December 19, 2007
Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteinsJue Zeng, Jizhou Yan, Ting Wang, et al.
Analytical Biochemistry|January 24, 2017
Split luciferase-based biosensors for characterizing EED bindersLing Li, Lijian Feng, Minlong Shi, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|October 20, 2006
Functional census of mutation sequence spaces: the example of p53 cancer rescue mutantsSamuel A Danziger, S Joshua Swamidass, Jue Zeng, et al.
Nature Communications|November 2, 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapiesElizabeth J Carstens, Kazuki Takahashi, Naoya Sakamoto, et al.
Journal of Medicinal Chemistry|December 20, 2016
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) MethyltransferaseAndreas Lingel, Martin Sendzik, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Pageof 3